Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Assets Average: 2024-2025

Historic Assets Average for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $1.1 billion.

  • Immunocore Holdings' Assets Average rose 3.65% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 3.65%. This contributed to the annual value of $803.3 million for FY2024, which is 42.96% up from last year.
  • Latest data reveals that Immunocore Holdings reported Assets Average of $1.1 billion as of Q3 2025, which was up 3.53% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Assets Average peaked at $1.1 billion during Q3 2025, and registered a low of $795.5 million during Q1 2024.
  • Over the past 2 years, Immunocore Holdings' median Assets Average value was $1.0 billion (recorded in 2024), while the average stood at $1.0 billion.
  • Data for Immunocore Holdings' Assets Average shows a peak YoY grew of 28.07% (in 2025) over the last 5 years.
  • Over the past 2 years, Immunocore Holdings' Assets Average (Quarterly) stood at $1.0 billion in 2024, then grew by 3.65% to $1.1 billion in 2025.
  • Its Assets Average stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.0 billion for Q1 2025.